Gamma announces Astrea, Avacta partnership

2020 04 14 17 10 6379 Test Tubes Rd Lab 400

Life sciences firm Gamma Biosciences has announced a licensing agreement between chromatography developer Astrea Bioseparations and biotherapeutic and reagent developer Avacta.

The licensing agreement gives Astrea access to Avacta's Affimer reagent technology for applications in bioprocessing, expanding its range of ligand discovery and development capabilities to include chemical and biological platforms for customer development programs, Gamma said.

Page 1 of 40
Next Page